Skip to main content
Clinical Trials/ACTRN12621001414808
ACTRN12621001414808
Recruiting
未知

Effect of Early enteral nutrition on the duration of hospital stay after Paediatric Ostomy Closure (EPOC): A Prospective Randomised Controlled Trial

Sydney Children's Hospital Network0 sites40 target enrollmentOctober 20, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Ostomy closure
Sponsor
Sydney Children's Hospital Network
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 20, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sydney Children's Hospital Network

Eligibility Criteria

Inclusion Criteria

  • Paediatric patients between the ages of 3 months and 16 years who can be expected to feed orally after undergoing elective enterostomy closure for the following indications and operation type;
  • \- Elective closure of colostomy after Anorectal malformation (ARM) repair
  • \- Elective closure of colostomy/ileostomy after pull\-through for Hirschsprung's disease (HSCR)
  • \- Elective closure of ileostomy after previous neonatal laparotomy for Necrotising enterocolitis (NEC), perforation, atresia or other intestinal pathology
  • \- Elective closure of colostomy/ileostomy where the stoma was formed at a previous laparotomy for other intra\-abdominal pathology.

Exclusion Criteria

  • Patients with short gut requiring long term total parenteral nutrition (TPN)
  • Patients undergoing a total colectomy or gastrostomy closure
  • Intercurrent conditions expected to affect bowel function (e.g., neurological impairment)
  • Patients who have been assessed to have unsafe swallow or laryngeal penetration with reflux and vomiting. This includes inability to protect the airway due to neurological impairment or structural abnormality, due to aspiration risk
  • Inability to obtain consent from parent/guardian
  • Patients requiring specific individualised feeding regime (e.g., metabolic disease)
  • Patients who require prolonged nasogastric tube (NGT) feeding
  • Patients requiring more than a simple enterostomy closure; i.e., extensive adhesiolysis or more than one anastomosis (in NEC)
  • Patients with Cystic Fibrosis or Inflammatory Bowel Disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials